世界のモノクローナルマウス抗体市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Monoclonal Mouse Antibody Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3911 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、モノクローナルマウス抗体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（IgM、IgG、IgA、その他）、用途別市場規模（治療、研究、診断）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・モノクローナルマウス抗体の市場動向 ・企業の競争状況、市場シェア ・モノクローナルマウス抗体の種類別市場規模（IgM、IgG、IgA、その他） ・モノクローナルマウス抗体の用途別市場規模（治療、研究、診断） ・モノクローナルマウス抗体の北米市場規模2016-2027（アメリカ、カナダ） ・モノクローナルマウス抗体のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・モノクローナルマウス抗体のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・モノクローナルマウス抗体の中南米市場規模2016-2027（メキシコ、ブラジル） ・モノクローナルマウス抗体の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Johnson & Johnson、Merck、Novartis、AbbVie、Amgen、Pfizer、Bayer、Lilly、Bristol-Myers Squibb、GlaxoSmithKline、Biogen、AstraZeneca、Sanofi、Alexion Pharmaceuticals、Seattle Genetics） ・結論

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
For antibody discovery, mice are one of the most important sources. They produce similar antibody isotypes with human, including IgA, IgD, IgE, IgG and IgM. Compared with the subclasses of human antibody isotypes, mice contain only one IgA class and the IgG subclasses are known as IgG1, IgG2a, IgG2b and IgG3. In addition, laboratory mice can induce a good immune response to a great range of antigens, even those highly homological human proteins. Moreover, some treatments that unacceptable for humans can also be aboveboard applied for mice with results which are analogous to that from humans. Therefore, the development of mouse monoclonal antibodies is a common choice for a variety of therapeutics and pathology researches. Up to now, the rapid development of therapeutic antibody in the pharmaceutical industry has enabled the mice to play an important role in both monoclonal antibodies discovery and the pre-clinical assessment.

Market Analysis and Insights: Global Monoclonal Mouse Antibody Market
The global Monoclonal Mouse Antibody market size is projected to reach US$ 11870 million by 2026, from US$ 8180.6 million in 2019, at a CAGR of 5.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Monoclonal Mouse Antibody market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Monoclonal Mouse Antibody market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Monoclonal Mouse Antibody market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Monoclonal Mouse Antibody market.

Global Monoclonal Mouse Antibody Scope and Market Size
Monoclonal Mouse Antibody market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Monoclonal Mouse Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
IgM
IgG
IgA
Others

Segment by Application
Therapeutic
Research
Diagnostic

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
Johnson & Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Novartis
AbbVie
Biogen
AstraZeneca
Sanofi

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal Mouse Antibody Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 IgM
1.2.3 IgG
1.2.4 IgA
1.2.5 Others
1.3 Market by Application
1.3.1 Global Monoclonal Mouse Antibody Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Therapeutic
1.3.3 Research
1.3.4 Diagnostic
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Monoclonal Mouse Antibody Market Perspective (2016-2027)
2.2 Monoclonal Mouse Antibody Growth Trends by Regions
2.2.1 Monoclonal Mouse Antibody Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Monoclonal Mouse Antibody Historic Market Share by Regions (2016-2021)
2.2.3 Monoclonal Mouse Antibody Forecasted Market Size by Regions (2022-2027)
2.3 Monoclonal Mouse Antibody Industry Dynamic
2.3.1 Monoclonal Mouse Antibody Market Trends
2.3.2 Monoclonal Mouse Antibody Market Drivers
2.3.3 Monoclonal Mouse Antibody Market Challenges
2.3.4 Monoclonal Mouse Antibody Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Mouse Antibody Players by Revenue
3.1.1 Global Top Monoclonal Mouse Antibody Players by Revenue (2016-2021)
3.1.2 Global Monoclonal Mouse Antibody Revenue Market Share by Players (2016-2021)
3.2 Global Monoclonal Mouse Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Monoclonal Mouse Antibody Revenue
3.4 Global Monoclonal Mouse Antibody Market Concentration Ratio
3.4.1 Global Monoclonal Mouse Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Mouse Antibody Revenue in 2020
3.5 Monoclonal Mouse Antibody Key Players Head office and Area Served
3.6 Key Players Monoclonal Mouse Antibody Product Solution and Service
3.7 Date of Enter into Monoclonal Mouse Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Monoclonal Mouse Antibody Breakdown Data by Type
4.1 Global Monoclonal Mouse Antibody Historic Market Size by Type (2016-2021)
4.2 Global Monoclonal Mouse Antibody Forecasted Market Size by Type (2022-2027)

5 Monoclonal Mouse Antibody Breakdown Data by Application
5.1 Global Monoclonal Mouse Antibody Historic Market Size by Application (2016-2021)
5.2 Global Monoclonal Mouse Antibody Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Monoclonal Mouse Antibody Market Size (2016-2027)
6.2 North America Monoclonal Mouse Antibody Market Size by Type
6.2.1 North America Monoclonal Mouse Antibody Market Size by Type (2016-2021)
6.2.2 North America Monoclonal Mouse Antibody Market Size by Type (2022-2027)
6.2.3 North America Monoclonal Mouse Antibody Market Size by Type (2016-2027)
6.3 North America Monoclonal Mouse Antibody Market Size by Application
6.3.1 North America Monoclonal Mouse Antibody Market Size by Application (2016-2021)
6.3.2 North America Monoclonal Mouse Antibody Market Size by Application (2022-2027)
6.3.3 North America Monoclonal Mouse Antibody Market Size by Application (2016-2027)
6.4 North America Monoclonal Mouse Antibody Market Size by Country
6.4.1 North America Monoclonal Mouse Antibody Market Size by Country (2016-2021)
6.4.2 North America Monoclonal Mouse Antibody Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Monoclonal Mouse Antibody Market Size (2016-2027)
7.2 Europe Monoclonal Mouse Antibody Market Size by Type
7.2.1 Europe Monoclonal Mouse Antibody Market Size by Type (2016-2021)
7.2.2 Europe Monoclonal Mouse Antibody Market Size by Type (2022-2027)
7.2.3 Europe Monoclonal Mouse Antibody Market Size by Type (2016-2027)
7.3 Europe Monoclonal Mouse Antibody Market Size by Application
7.3.1 Europe Monoclonal Mouse Antibody Market Size by Application (2016-2021)
7.3.2 Europe Monoclonal Mouse Antibody Market Size by Application (2022-2027)
7.3.3 Europe Monoclonal Mouse Antibody Market Size by Application (2016-2027)
7.4 Europe Monoclonal Mouse Antibody Market Size by Country
7.4.1 Europe Monoclonal Mouse Antibody Market Size by Country (2016-2021)
7.4.2 Europe Monoclonal Mouse Antibody Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Mouse Antibody Market Size (2016-2027)
8.2 Asia-Pacific Monoclonal Mouse Antibody Market Size by Type
8.2.1 Asia-Pacific Monoclonal Mouse Antibody Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Monoclonal Mouse Antibody Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Monoclonal Mouse Antibody Market Size by Type (2016-2027)
8.3 Asia-Pacific Monoclonal Mouse Antibody Market Size by Application
8.3.1 Asia-Pacific Monoclonal Mouse Antibody Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Monoclonal Mouse Antibody Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Monoclonal Mouse Antibody Market Size by Application (2016-2027)
8.4 Asia-Pacific Monoclonal Mouse Antibody Market Size by Region
8.4.1 Asia-Pacific Monoclonal Mouse Antibody Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Monoclonal Mouse Antibody Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Monoclonal Mouse Antibody Market Size (2016-2027)
9.2 Latin America Monoclonal Mouse Antibody Market Size by Type
9.2.1 Latin America Monoclonal Mouse Antibody Market Size by Type (2016-2021)
9.2.2 Latin America Monoclonal Mouse Antibody Market Size by Type (2022-2027)
9.2.3 Latin America Monoclonal Mouse Antibody Market Size by Type (2016-2027)
9.3 Latin America Monoclonal Mouse Antibody Market Size by Application
9.3.1 Latin America Monoclonal Mouse Antibody Market Size by Application (2016-2021)
9.3.2 Latin America Monoclonal Mouse Antibody Market Size by Application (2022-2027)
9.3.3 Latin America Monoclonal Mouse Antibody Market Size by Application (2016-2027)
9.4 Latin America Monoclonal Mouse Antibody Market Size by Country
9.4.1 Latin America Monoclonal Mouse Antibody Market Size by Country (2016-2021)
9.4.2 Latin America Monoclonal Mouse Antibody Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Mouse Antibody Market Size (2016-2027)
10.2 Middle East & Africa Monoclonal Mouse Antibody Market Size by Type
10.2.1 Middle East & Africa Monoclonal Mouse Antibody Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Monoclonal Mouse Antibody Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Monoclonal Mouse Antibody Market Size by Type (2016-2027)
10.3 Middle East & Africa Monoclonal Mouse Antibody Market Size by Application
10.3.1 Middle East & Africa Monoclonal Mouse Antibody Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Monoclonal Mouse Antibody Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Monoclonal Mouse Antibody Market Size by Application (2016-2027)
10.4 Middle East & Africa Monoclonal Mouse Antibody Market Size by Country
10.4.1 Middle East & Africa Monoclonal Mouse Antibody Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Monoclonal Mouse Antibody Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Monoclonal Mouse Antibody Introduction
11.1.4 Roche Revenue in Monoclonal Mouse Antibody Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Monoclonal Mouse Antibody Introduction
11.2.4 Johnson & Johnson Revenue in Monoclonal Mouse Antibody Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Monoclonal Mouse Antibody Introduction
11.3.4 Merck Revenue in Monoclonal Mouse Antibody Business (2016-2021)
11.3.5 Merck Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Monoclonal Mouse Antibody Introduction
11.4.4 Novartis Revenue in Monoclonal Mouse Antibody Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 AbbVie
11.5.1 AbbVie Company Details
11.5.2 AbbVie Business Overview
11.5.3 AbbVie Monoclonal Mouse Antibody Introduction
11.5.4 AbbVie Revenue in Monoclonal Mouse Antibody Business (2016-2021)
11.5.5 AbbVie Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Monoclonal Mouse Antibody Introduction
11.6.4 Amgen Revenue in Monoclonal Mouse Antibody Business (2016-2021)
11.6.5 Amgen Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Monoclonal Mouse Antibody Introduction
11.7.4 Pfizer Revenue in Monoclonal Mouse Antibody Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Bayer
11.8.1 Bayer Company Details
11.8.2 Bayer Business Overview
11.8.3 Bayer Monoclonal Mouse Antibody Introduction
11.8.4 Bayer Revenue in Monoclonal Mouse Antibody Business (2016-2021)
11.8.5 Bayer Recent Development
11.9 Lilly
11.9.1 Lilly Company Details
11.9.2 Lilly Business Overview
11.9.3 Lilly Monoclonal Mouse Antibody Introduction
11.9.4 Lilly Revenue in Monoclonal Mouse Antibody Business (2016-2021)
11.9.5 Lilly Recent Development
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Details
11.10.2 Bristol-Myers Squibb Business Overview
11.10.3 Bristol-Myers Squibb Monoclonal Mouse Antibody Introduction
11.10.4 Bristol-Myers Squibb Revenue in Monoclonal Mouse Antibody Business (2016-2021)
11.10.5 Bristol-Myers Squibb Recent Development
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Details
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline Monoclonal Mouse Antibody Introduction
11.11.4 GlaxoSmithKline Revenue in Monoclonal Mouse Antibody Business (2016-2021)
11.11.5 GlaxoSmithKline Recent Development
11.12 Biogen
11.12.1 Biogen Company Details
11.12.2 Biogen Business Overview
11.12.3 Biogen Monoclonal Mouse Antibody Introduction
11.12.4 Biogen Revenue in Monoclonal Mouse Antibody Business (2016-2021)
11.12.5 Biogen Recent Development
11.13 AstraZeneca
11.13.1 AstraZeneca Company Details
11.13.2 AstraZeneca Business Overview
11.13.3 AstraZeneca Monoclonal Mouse Antibody Introduction
11.13.4 AstraZeneca Revenue in Monoclonal Mouse Antibody Business (2016-2021)
11.13.5 AstraZeneca Recent Development
11.14 Sanofi
11.14.1 Sanofi Company Details
11.14.2 Sanofi Business Overview
11.14.3 Sanofi Monoclonal Mouse Antibody Introduction
11.14.4 Sanofi Revenue in Monoclonal Mouse Antibody Business (2016-2021)
11.14.5 Sanofi Recent Development
11.15 Alexion Pharmaceuticals
11.15.1 Alexion Pharmaceuticals Company Details
11.15.2 Alexion Pharmaceuticals Business Overview
11.15.3 Alexion Pharmaceuticals Monoclonal Mouse Antibody Introduction
11.15.4 Alexion Pharmaceuticals Revenue in Monoclonal Mouse Antibody Business (2016-2021)
11.15.5 Alexion Pharmaceuticals Recent Development
11.16 Seattle Genetics
11.16.1 Seattle Genetics Company Details
11.16.2 Seattle Genetics Business Overview
11.16.3 Seattle Genetics Monoclonal Mouse Antibody Introduction
11.16.4 Seattle Genetics Revenue in Monoclonal Mouse Antibody Business (2016-2021)
11.16.5 Seattle Genetics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Monoclonal Mouse Antibody Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of IgM
Table 3. Key Players of IgG
Table 4. Key Players of IgA
Table 5. Key Players of Others
Table 6. Global Monoclonal Mouse Antibody Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Monoclonal Mouse Antibody Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Monoclonal Mouse Antibody Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Monoclonal Mouse Antibody Market Share by Regions (2016-2021)
Table 10. Global Monoclonal Mouse Antibody Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Monoclonal Mouse Antibody Market Share by Regions (2022-2027)
Table 12. Monoclonal Mouse Antibody Market Trends
Table 13. Monoclonal Mouse Antibody Market Drivers
Table 14. Monoclonal Mouse Antibody Market Challenges
Table 15. Monoclonal Mouse Antibody Market Restraints
Table 16. Global Monoclonal Mouse Antibody Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Monoclonal Mouse Antibody Market Share by Players (2016-2021)
Table 18. Global Top Monoclonal Mouse Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Mouse Antibody as of 2020)
Table 19. Ranking of Global Top Monoclonal Mouse Antibody Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Monoclonal Mouse Antibody Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Monoclonal Mouse Antibody Product Solution and Service
Table 23. Date of Enter into Monoclonal Mouse Antibody Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Monoclonal Mouse Antibody Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Monoclonal Mouse Antibody Revenue Market Share by Type (2016-2021)
Table 27. Global Monoclonal Mouse Antibody Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Monoclonal Mouse Antibody Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Monoclonal Mouse Antibody Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Monoclonal Mouse Antibody Revenue Market Share by Application (2016-2021)
Table 31. Global Monoclonal Mouse Antibody Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Monoclonal Mouse Antibody Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Monoclonal Mouse Antibody Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Monoclonal Mouse Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Monoclonal Mouse Antibody Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Monoclonal Mouse Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Monoclonal Mouse Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Monoclonal Mouse Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Monoclonal Mouse Antibody Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Monoclonal Mouse Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Monoclonal Mouse Antibody Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Monoclonal Mouse Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Monoclonal Mouse Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Monoclonal Mouse Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Monoclonal Mouse Antibody Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Monoclonal Mouse Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Monoclonal Mouse Antibody Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Monoclonal Mouse Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Monoclonal Mouse Antibody Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Monoclonal Mouse Antibody Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Monoclonal Mouse Antibody Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Monoclonal Mouse Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Monoclonal Mouse Antibody Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Monoclonal Mouse Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Monoclonal Mouse Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Monoclonal Mouse Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Monoclonal Mouse Antibody Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Monoclonal Mouse Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Monoclonal Mouse Antibody Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Monoclonal Mouse Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Monoclonal Mouse Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Monoclonal Mouse Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Monoclonal Mouse Antibody Product
Table 66. Roche Revenue in Monoclonal Mouse Antibody Business (2016-2021) & (US$ Million)
Table 67. Roche Recent Development
Table 68. Johnson & Johnson Company Details
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Monoclonal Mouse Antibody Product
Table 71. Johnson & Johnson Revenue in Monoclonal Mouse Antibody Business (2016-2021) & (US$ Million)
Table 72. Johnson & Johnson Recent Development
Table 73. Merck Company Details
Table 74. Merck Business Overview
Table 75. Merck Monoclonal Mouse Antibody Product
Table 76. Merck Revenue in Monoclonal Mouse Antibody Business (2016-2021) & (US$ Million)
Table 77. Merck Recent Development
Table 78. Novartis Company Details
Table 79. Novartis Business Overview
Table 80. Novartis Monoclonal Mouse Antibody Product
Table 81. Novartis Revenue in Monoclonal Mouse Antibody Business (2016-2021) & (US$ Million)
Table 82. Novartis Recent Development
Table 83. AbbVie Company Details
Table 84. AbbVie Business Overview
Table 85. AbbVie Monoclonal Mouse Antibody Product
Table 86. AbbVie Revenue in Monoclonal Mouse Antibody Business (2016-2021) & (US$ Million)
Table 87. AbbVie Recent Development
Table 88. Amgen Company Details
Table 89. Amgen Business Overview
Table 90. Amgen Monoclonal Mouse Antibody Product
Table 91. Amgen Revenue in Monoclonal Mouse Antibody Business (2016-2021) & (US$ Million)
Table 92. Amgen Recent Development
Table 93. Pfizer Company Details
Table 94. Pfizer Business Overview
Table 95. Pfizer Monoclonal Mouse Antibody Product
Table 96. Pfizer Revenue in Monoclonal Mouse Antibody Business (2016-2021) & (US$ Million)
Table 97. Pfizer Recent Development
Table 98. Bayer Company Details
Table 99. Bayer Business Overview
Table 100. Bayer Revenue in Monoclonal Mouse Antibody Business (2016-2021) & (US$ Million)
Table 101. Bayer Recent Development
Table 102. Lilly Company Details
Table 103. Lilly Business Overview
Table 104. Lilly Monoclonal Mouse Antibody Product
Table 105. Lilly Revenue in Monoclonal Mouse Antibody Business (2016-2021) & (US$ Million)
Table 106. Lilly Recent Development
Table 107. Bristol-Myers Squibb Company Details
Table 108. Bristol-Myers Squibb Business Overview
Table 109. Bristol-Myers Squibb Monoclonal Mouse Antibody Product
Table 110. Bristol-Myers Squibb Revenue in Monoclonal Mouse Antibody Business (2016-2021) & (US$ Million)
Table 111. Bristol-Myers Squibb Recent Development
Table 112. GlaxoSmithKline Company Details
Table 113. GlaxoSmithKline Business Overview
Table 114. GlaxoSmithKline Monoclonal Mouse Antibody Product
Table 115. GlaxoSmithKline Revenue in Monoclonal Mouse Antibody Business (2016-2021) & (US$ Million)
Table 116. GlaxoSmithKline Recent Development
Table 117. Biogen Company Details
Table 118. Biogen Business Overview
Table 119. Biogen Monoclonal Mouse Antibody Product
Table 120. Biogen Revenue in Monoclonal Mouse Antibody Business (2016-2021) & (US$ Million)
Table 121. Biogen Recent Development
Table 122. AstraZeneca Company Details
Table 123. AstraZeneca Business Overview
Table 124. AstraZeneca Monoclonal Mouse Antibody Product
Table 125. AstraZeneca Revenue in Monoclonal Mouse Antibody Business (2016-2021) & (US$ Million)
Table 126. AstraZeneca Recent Development
Table 127. Sanofi Company Details
Table 128. Sanofi Business Overview
Table 129. Sanofi Monoclonal Mouse Antibody Product
Table 130. Sanofi Revenue in Monoclonal Mouse Antibody Business (2016-2021) & (US$ Million)
Table 131. Sanofi Recent Development
Table 132. Alexion Pharmaceuticals Company Details
Table 133. Alexion Pharmaceuticals Business Overview
Table 134. Alexion Pharmaceuticals Monoclonal Mouse Antibody Product
Table 135. Alexion Pharmaceuticals Revenue in Monoclonal Mouse Antibody Business (2016-2021) & (US$ Million)
Table 136. Alexion Pharmaceuticals Recent Development
Table 137. Seattle Genetics Company Details
Table 138. Seattle Genetics Business Overview
Table 139. Seattle Genetics Monoclonal Mouse Antibody Product
Table 140. Seattle Genetics Revenue in Monoclonal Mouse Antibody Business (2016-2021) & (US$ Million)
Table 141. Seattle Genetics Recent Development
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monoclonal Mouse Antibody Market Share by Type: 2020 VS 2027
Figure 2. IgM Features
Figure 3. IgG Features
Figure 4. IgA Features
Figure 5. Others Features
Figure 6. Global Monoclonal Mouse Antibody Market Share by Application: 2020 VS 2027
Figure 7. Therapeutic Case Studies
Figure 8. Research Case Studies
Figure 9. Diagnostic Case Studies
Figure 10. Monoclonal Mouse Antibody Report Years Considered
Figure 11. Global Monoclonal Mouse Antibody Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Monoclonal Mouse Antibody Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Monoclonal Mouse Antibody Market Share by Regions: 2020 VS 2027
Figure 14. Global Monoclonal Mouse Antibody Market Share by Regions (2022-2027)
Figure 15. Global Monoclonal Mouse Antibody Market Share by Players in 2020
Figure 16. Global Top Monoclonal Mouse Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Mouse Antibody as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Monoclonal Mouse Antibody Revenue in 2020
Figure 18. Global Monoclonal Mouse Antibody Revenue Market Share by Type (2016-2021)
Figure 19. Global Monoclonal Mouse Antibody Revenue Market Share by Type (2022-2027)
Figure 20. North America Monoclonal Mouse Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Monoclonal Mouse Antibody Market Share by Type (2016-2027)
Figure 22. North America Monoclonal Mouse Antibody Market Share by Application (2016-2027)
Figure 23. North America Monoclonal Mouse Antibody Market Share by Country (2016-2027)
Figure 24. United States Monoclonal Mouse Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Monoclonal Mouse Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Monoclonal Mouse Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Monoclonal Mouse Antibody Market Share by Type (2016-2027)
Figure 28. Europe Monoclonal Mouse Antibody Market Share by Application (2016-2027)
Figure 29. Europe Monoclonal Mouse Antibody Market Share by Country (2016-2027)
Figure 30. Germany Monoclonal Mouse Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Monoclonal Mouse Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Monoclonal Mouse Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Monoclonal Mouse Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Monoclonal Mouse Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Monoclonal Mouse Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Monoclonal Mouse Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Monoclonal Mouse Antibody Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Monoclonal Mouse Antibody Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Monoclonal Mouse Antibody Market Share by Region (2016-2027)
Figure 40. China Monoclonal Mouse Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Monoclonal Mouse Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Monoclonal Mouse Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Monoclonal Mouse Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Monoclonal Mouse Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Monoclonal Mouse Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Monoclonal Mouse Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Monoclonal Mouse Antibody Market Share by Type (2016-2027)
Figure 48. Latin America Monoclonal Mouse Antibody Market Share by Application (2016-2027)
Figure 49. Latin America Monoclonal Mouse Antibody Market Share by Country (2016-2027)
Figure 50. Mexico Monoclonal Mouse Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Monoclonal Mouse Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Monoclonal Mouse Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Monoclonal Mouse Antibody Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Monoclonal Mouse Antibody Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Monoclonal Mouse Antibody Market Share by Country (2016-2027)
Figure 56. Turkey Monoclonal Mouse Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Monoclonal Mouse Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Monoclonal Mouse Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Roche Revenue Growth Rate in Monoclonal Mouse Antibody Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Monoclonal Mouse Antibody Business (2016-2021)
Figure 61. Merck Revenue Growth Rate in Monoclonal Mouse Antibody Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Monoclonal Mouse Antibody Business (2016-2021)
Figure 63. AbbVie Revenue Growth Rate in Monoclonal Mouse Antibody Business (2016-2021)
Figure 64. Amgen Revenue Growth Rate in Monoclonal Mouse Antibody Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Monoclonal Mouse Antibody Business (2016-2021)
Figure 66. Bayer Revenue Growth Rate in Monoclonal Mouse Antibody Business (2016-2021)
Figure 67. Lilly Revenue Growth Rate in Monoclonal Mouse Antibody Business (2016-2021)
Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Monoclonal Mouse Antibody Business (2016-2021)
Figure 69. GlaxoSmithKline Revenue Growth Rate in Monoclonal Mouse Antibody Business (2016-2021)
Figure 70. Biogen Revenue Growth Rate in Monoclonal Mouse Antibody Business (2016-2021)
Figure 71. AstraZeneca Revenue Growth Rate in Monoclonal Mouse Antibody Business (2016-2021)
Figure 72. Sanofi Revenue Growth Rate in Monoclonal Mouse Antibody Business (2016-2021)
Figure 73. Alexion Pharmaceuticals Revenue Growth Rate in Monoclonal Mouse Antibody Business (2016-2021)
Figure 74. Seattle Genetics Revenue Growth Rate in Monoclonal Mouse Antibody Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

---